Author Archives: Brian Nichols

Brian Nichols is the Founder and Editor-in-Chief of BNL Finance. Brian is also a contributor. For BNL Members, Brian heads the Stock Research and Stock Target services. Brian also founded the BNL Portfolio, where all trades and equity positions are tracked and presented to BNL Members. Prior to founding BNL Finance, Brian founded and managed a popular subscription-based research service called Tipping the Scale, where 100s of investors could access stock and market research along with investing ideas based on Brian’s own personal investment philosophy. Many of the same ideas and services that made Tipping the Scale successful are behind BNL’s Membership program, only better. Brian has published 1,000s of articles covering just about every industry of the market, and is the author of “Taking Charge With Value Investing (McGraw-Hill, 2012). He is known for calling bottoms and making great investments in stocks like XPO, RAD, S, FB, NFLX, AAPL, ACAD, PCYC, UA, DAL, JAZZ, and previously acquired companies like Santarus, Salix Pharmaceutucals, Questcor Pharmaceuticals, and King Digital among others. Brian’s BNL Portfolio was previously referred to as “TTS Portfolio” and “My Portfolio” on Seeking Alpha and Tipping the Scale. Brian can be reached at

XPO Logistics (NYSE:XPO) Stock Breaks Out Ahead of Earnings, Like Clockwork!

XPO stock trends higher ahead of XPO Logistics Inc (NYSE:XPO) first quarter earnings, and is likely to reach new highs next week.

Posted in Editor's Pick, HADE Platform, Hot Stocks, Industrials, Members | Tagged , | 1 Comment

Why Sprint Corp (NYSE:S) Is Worse Than Valeant Pharmaceuticals (NYSE:VRX)

Sprint Corp (NYSE:S) debt and losses prove that Sprint stock is actually worse than Valeant Pharmaceuticals (NYSE:VRX) stock.

Posted in Members, Technology, Timely Analysis | Tagged , , , , , | 6 Comments

Valeant Pharmaceuticals (NYSE:VRX) Stock: Time to Face the Ugly Truth

Valeant Pharmaceuticals (NYSE:VRX) is not Netflix (NASDAQ:NFLX). Bill Ackman’s divestment & VRX stock price suggests an ugly truth for Valeant stock owners.

Posted in Editor's Pick, Healthcare & Biotech, Members, Timely Analysis | Tagged , , , | 3 Comments

Fannie Mae & Freddie Mac: Why FNMA Stock & FMCC Stock Are A Buy Right Now!

FNMA stock nor FMCC stock takes into account Steve Mnuchin’s role or desire for GSE reform to free Fannie Mae and Freddie Mac for conservatorship.

Posted in Financial, Hot Stocks, Members, Politics | Tagged , , , | 4 Comments

Proof That Barron’s Is Right About Under Armour Inc (UAA) (UA) Stock

Barron’s is right about UA stock, and we have the perfect illustration to compare Under Armour Inc (NYSE:UA) (NYSE:UAA) to Nike Inc (NYSE:NKE).

Posted in Retail, Stock Ratings, Timely Analysis | Tagged , , , , | Leave a comment

Why Celgene Corporation (NASDAQ:CELG) Stock Looks Ready to Breakout

Revlimid, Otezla, and Ozanimod are three Celgene Corporation (NASDAQ:CELG) drugs that will drive CELG stock higher over the next few years.

Posted in Healthcare & Biotech, Members | Tagged , | Leave a comment

Is Live Nation Entertainment (NYSE:LYV) Stock The Perfect Short With Significant Downside Ahead?

Live Nation Entertainment (NYSE:LYV) may be a monopoly with Ticketmaster and countless venues, but LYV stock may also be a great short.

Posted in Members, Request Coverage | Tagged , | Leave a comment